logo góra






























































Publikacje IZOWWN

1. Chwirot B.W., Z. Michniewicz, M. Kowalska, J. Nussbeutel: Detection of Colonic Malignant Lesions by Digital Imaging of Ultraviolet Laser - Induced Autofluorescence. Photochem. Photobiol. 69, 336 - 340 (1999)
2. Chwirot B.W., M. Kowalska, N. Sypniewska, Z. Michniewicz, M. Grądziel: Spectrally Resolved Fluorescence Imaging of Human Colonic Adenomas. J. Photochem. Photobiol. B: Biol. 50, 174-183 (1999)
3. Chwirot B.W., M. Jackowski, A. Brożyna, M. Piwiński: Optical biopsy of lesions and normal mucosa in human stomach: in vivo and in vitro study. Folia Histochem. Cytobiol. 37S1, 8 (1999)
4. Chwirot B.W., M. Kowalska, M. Grądziel, Z. Michniewicz: Fluorescence microscopic studies on localisation and nature of native fluorophores in normal mucosa and malignant lesions of human colon. Folia Histochem. Cytobiol. 37S1, 8 (1999)
5. Chwirot B.W., N. Sypniewska, M. Grądziel, M. Piwiński: In vitro autofluorescence of human skin: contribution of individual skin layers. Folia Histochem. Cytobiol. 37S1, 9 (1999)
6. Chwirot B.W., M. Kowalska, N. Sypniewska, Z. Michniewicz, M. Grądziel: Spectrally resolved imaging of UV laser - excited fluorescence of human colonic adenomas. str. 93-98 w R. Maniewski, G. Nilson i H. Wierzba (red.): Optoelectronics in Medical Diagnosis. Lecture Notes of the ICB Seminars, Międzynarodowe Centrum Biocybernetyki PAN - WHO, Warszawa (2000)
7. Chwirot B.W., S. Chwirot, N. Sypniewska, Z. Michniewicz, J. Redziński, G. Kurzawski, W. Ruka: Fluorescence in situ Detection of Human Cutaneous Melanoma: Study of Diagnostic Parameters of the Method. - J. Invest. Dermatol. 117, 1449-1451 (2001)
8. Chwirot B.W., N. Sypniewska, J. Światlak: Diagnostic potential of fluorescence of formalin - fixed paraffin - embedded malignant melanoma and pigmented skin lesions. Quantitative study of fluorescence intensity using fluorescence microscope and digital imaging. Melanoma Res 11, 569-576 (2001)
9. Sypniewska N., B.W. Chwirot, E. Barcikowska: Significant difference in intensity of formalin – induced fluorescence of melanomas in horizontal and vertical growth phase. Pigment Cell Res. 15 (S9), 67 (2002)
10. Chwirot B.W., S. Chwirot, N. Sypniewska: Fluorescence in situ detection of human cutaneous melanoma: diagnostic parameters of the method. Pigment Cell Res. 15 (S9), 43 (2002)
11. Brożyna A., K. Kwiatkowska, B.W. Chwirot: The induction of nuclear DNA breaks in human skin cells by ultraviolet A (UVA) light. Cell. Mol. Biol. Lett. 7, 86 (2002)
12. Sypniewska N., E. Barcikowska, B.W. Chwirot: Formalin – induced fluorescence (FIF) as an auxiliary tool for the histopathological diagnosis of human cutaneous melanoma. Cell. Mol. Biol. Lett. 7, 107 (2002)
13. Chwirot B.W., N. Sypniewska, E. Barcikowska: Quantitative measurements of the fluorescence intensity – new method for a detection of melanoma cells in histopathological preparations. Optica Applicata, Vol. XXXII, No. 4 (2002)
14. Chwirot B.W. i S. Chwirot: Fluorescence detection of human tumours without photosensitisers. Optica Applicata, Vol. XXXII, No. 4 (2002)
15. Chwirot B.W., M. Kowalska, N. Płóciennik, M. Piwiński, Z. Michniewicz, S. Chwirot: Variability of spectra of laser-induced fluorescence of colonic mucosa: Its significance for fluorescence detection of colonic neoplasia. Ind. J. Exp. Biol. 41, 500-510 (2003)
16. Chwirot B.W. i S. Chwirot: Piętnaście lat badań nad zastosowaniem autofluorescencji komórek i tkanek do wykrywania zmian przednowotworowych i nowotworów u człowieka. Rozdział 5 w H. Podbielska, A. Sieroń, W. Stręk (red.): Diagnostyka i terapia fotodynamiczna. Wydawnictwo Medyczne Urban&Partner, Wrocław, 2004
17. Brożyna A. i B.W. Chwirot: Different susceptibility of cells of porcine skin and internal organs to ultraviolet A-induced breaking of nuclear DNA. Photochem. Photobiol. 81, 674-681 (2005)
18. Chwirot B. W. i S. Chwirot: Endogenous fluorescence - new approach to in situ detection of premalignant and malignant lesions in human organs. Proc. SPIE 5849, 47-55 (2005)
19. Niedojadło K., K. Łabędzka, E. Łada, A. Milewska, B.W. Chwirot: Apaf-1 expression in human cutaneous melanoma progression and in pigmented nevi. Pigment Cell Res. 19, 43-50 (2005)
20. Brożyna A., K. Fidos, B.W. Chwirot: Different efficiency of UV-induction of DNA breaks by pulsed and continuously delivered laser radiation. Folia Histochem. Cytobiol. 43 S1, 51-52 (2005)
21. Kuźbicki Ł., E. Aładowicz, B.W. Chwirot: Differences in expression of CDK-2 in cutaneous melanomas and benign melanocytic lesions in human. Folia Histochem. Cytobiol. 43 S1, 60-61 (2005)
22. Kuźbicki Ł., A. Sarnecka, B.W. Chwirot: Expression of cyclooxygenase 2 in human malignant and benign melanocytic tumours. Folia Histochem. Cytobiol. 43 S1, 61 (2005)
23. Niedojadło K., E. Łada, A. Milewska, B.W. Chwirot: Apaf-1 expression in human skin, pigmented lesions, melanomas and melanoma lymph node metastases. Folia Histochem. Cytobiol. 43 S1, 65-66 (2005)
24. 25. Sztramska A., B. Dybciak, B.W. Chwirot: Formalin-induced fluorescence of human malignant melanoma and benign pigmented skin lesions. Folia Histochem. Cytobiol. 43 S1, 73-74 (2005)
26. Brożyna A., B.W. Chwirot: Porcine Skin As a Model System for Studies of Ultraviolet A Effects in Human Skin, J. Toxicol. Environ. Health A 69, 1155-1165 (2006)
27. Kuźbicki Ł., A. Sarnecka, B.W. Chwirot: Expression of cyclooxygenase-2 in benign nevi and during human cutaneous melanoma progression. Melanoma Res. 16 (1): 29-36 (2006)
28. Kuźbicki Ł., B. Gajo, B.W. Chwirot: Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions. Melanoma Res. 16 (3): 235-243 (2006)
29. Kuźbicki Ł., E. Aładowicz, B.W. Chwirot: Cyclin-dependent kinase 2 expression in human melanomas and benign melanocytic skin lesions. Melanoma Res. 16 (5): 435-444 (2006)
30. Chwirot B.W., Ł. Kuźbicki: Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours. Melanoma Res. 17 (3): 139-145 (2007)
31. Brożyna A., B. Zbytek, J. Granese, C.J. Andrew, J. Ross, A. Slominski: Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma. Expert. Rev. Dermatol. 2 (4): 451-469 (2007)
32. Brożyna A., L. VanMiddlesworth, A. Slominski: Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy, Int. J. Cancer. 123 (6):1448-1456 (2008)
33. Sztramska A., D. Dymerska, B.W. Chwirot: Skin layer-specific Melan-A expression during progression of human cutaneous melanoma: implications for diagnostic applications of the marker. Melanoma Res. 18 (4):259-267 (2008)
34. Kuźbicki Ł., D. Lange, A. Piksa, A. Misz, B.W. Chwirot: Different expression of cyclin-dependent kinase 2 (CDK-2) in benign and malignant nonmelanocytic human skin lesions. Med. Biol. Sci. 23 S2, 36 (2009)
35. Kuźbicki Ł., D. Lange, E. Róg-Zielińska, J. Rzemek, B.W. Chwirot: Cyclooxygenase (COX-2) expression in selected nonmelanocytic human skin lesions. Med. Biol. Sci. 23 S2, 36-37 (2009)
36. Kuźbicki Ł., D. Lange, D. Słowińska, J. Urban, G. Szatkowski, B.W. Chwirot: Cyclooxygenase-2 (COX-2) expression in human melanocytic nevi and cutaneous melanomas - immunohistochemistry with two different types of antibodies. Med. Biol. Sci. 23 S2, 37 (2009)
37. Kuźbicki Ł., D. Lange, B.W. Chwirot: Cyclooxygenase-2 immunohistochemistry in human melanoma: differences between results obtained with different antibodies. Melanoma Res. 19 (5): 294-300 (2009)
38. Sztramska A., M. Piwiński, B.W. Chwirot: Quantitative measurements of formalin-induced fluorescence for differential diagnostics of melanomas and lesions of human skin. Melanoma Res. 20 (5): 408-416 (2010)
39. Kuźbicki Ł., D. Lange, A. Stanek-Widera, B.W. Chwirot: Cyclin-dependent kinase (CDK-2) expression in non-melanocytic human cutaneous lesions. Appl Immunohistochem Mol Morphol. 18 (4): 357-364 (2010)
40. Szatkowski G., D. Dziczek, B.W. Chwirot: Biological effects of irradiation of rat blood vessel cells with 308 nm pulses of Xe-Cl excimer laser - design of experiment and first results. Curr Top Biophys. 33 Suppl. B 55 (2010)
41. Szatkowski G., D. Dziczek, Ł. Kuźbicki, G. Sworowski, B.W. Chwirot: Susceptibility of cells of rat femoral artery wall to ultraviolet UVB light - induced breaking of nuclear DNA. Acta Biochim Pol. 58 S2 288 (2011)
42. Urban J., B.W. Chwirot: Epithelial and stromal COX-2 expression as a potential marker of progression of human breast tumors. Acta Biochim Pol. 58 S2 77 (2011)
43. Urban J., Ł. Kuźbicki, B.W. Chwirot: Ekspresja cyklooksygenazy 2 (COX-2) w nowotworach piersi człowieka. Wsp Onkol. 15 S1 99 (2011)
44. Kuźbicki Ł., D. Lange, A. Strączyńska-Niemiec, B.W. Chwirot: Diagnostic potential of cyclooxygenase-2 immunohistochemical expression for differentiating between melanocytic naevi and early human cutaneous melanomas. Wsp Onkol. 15 S1 94-95 (2011)
45. Chwirot B.W., J. Urban, Ł. Kuźbicki: Cyclooxygenase-2 overexpression as indicator of favorable clinicopathological phenotype and better survival of colorectal cancer patients: Fact or artifact? Basic & Applied Pathology 4: 33 (2011)
46. Kuźbicki Ł., D. Lange, A. Stanek-Widera, B.W. Chwirot: Different expression of cyclooxygenase-2 (COX-2) in selected nonmelanocytic human cutaneous lesions. Folia Histochem Cytobiol. 49 (3): 381-388 (2011)
47. Szatkowski G., D. Dziczek, B.W. Chwirot: Ocena podatności komórek ściany tętnicy udowej szczura na indukcję pęknięć jądrowego DNA impulsowym promieniowaniem UVB i kinetyki ich naprawy. Post Biol Kom. 39, S27 32 (2012)
48. Urban J., Ł. Kuźbicki, B.W. Chwirot: Ekspresja cyklooksygenazy 2 (COX-2) w makrofagach jako potencjalny marker prognostyczny w nowotworach jelita grubego człowieka. Post Biol Kom. 39 S27 29 (2012)
49. Kuźbicki Ł, J. Urban, B.W. Chwirot: Immunohistochemiczna wykrywalność ekspresji cyklooksygenazy-2 (COX-2) w mikromacierzach tkankowych i standardowych preparatach histopatologicznych jako markera czerniaka u człowieka. Post Biol Kom. 39 S27 40 (2012)
50. Kuźbicki Ł., D. Lange, A. Strączyńska-Niemiec, B.W. Chwirot: The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions. Melanoma Res. 22 (1): 70-76 (2012)
51. Kuźbicki Ł., D. Lange, A. Strączyńska-Niemiec, B.W. Chwirot: Diagnostic potential of JARID1B expression in differentiating between early melanomas and benign human skin lesions. Acta Biochim Pol. 60 S1 106 (2013)
52. Urban J., Ł. Kuźbicki, B.W. Chwirot: Stromal COX-2 expression as a marker of human breast cancer invasiveness. Acta Biochim Pol. 60, S1 113 (2013)
53. Kuźbicki Ł., D. Lange, A. Strączyńska-Niemiec, B.W. Chwirot: JARID1B expression in human melanoma and benign melanocytic skin lesions. Melanoma Res. 23 (1): 8-12 (2013)
54. Kuźbicki Ł., J. Urban, B.W. Chwirot: Different detectability of cyclooxygenase-2 (COX-2) protein in standard paraffin sections and tissue microarrays of human melanomas and naevi – Comparative study. Pathol Res Pract. 210 (9): 591-595 (2014)
55. Urban J., Ł. Kuźbicki, G. Szatkowski, A. Stanek-Widera, D. Lange, B.W. Chwirot: Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients. BMC Cancer. 14 (732) http://www.biomedcentral.com/1471-2407/14/732 (2014)
56. Kuźbicki Ł., D. Lange, A. Strączyńska-Niemiec, B.W. Chwirot: Altered splicing of JARID1B in development of human cutaneous melanoma? Appl Immunohistochem Mol Morphol. doi: 10.1097/PAI.0000000000000170 (2015)